Literature DB >> 8584045

Inhibition by carbamazepine of various ion channels-mediated catecholamine secretion in cultured bovine adrenal medullary cells.

R Yoshimura1, N Yanagihara, T Terao, K Minami, K Abe, F Izumi.   

Abstract

The effects of carbamazepine (CBZ) on 22Na+ influx, 45Ca2- influx, catecholamine secretion and cyclic GMP production were examined in cultured bovine adrenal medullary cells. 1) CBZ (40-120 mumol/l) inhibited 22Na+ influx evoked by carbachol in a concentration-dependent manner. CBZ inhibited carbachol-evoked 45Ca2- influx and catecholamine secretion at concentrations similar to those which suppressed 22Na+ influx. 2) CBZ (4-120 mumol/l) inhibited veratridine-induced 22Na+ influx, 45Ca2+ influx and catecholamine secretion. 3) CBZ (12 or 40-120 mumol/l) suppressed 56 mmol/l K(+)-evoked 45Ca2+ influx and catecholamine secretion, respectively. 4) Combination of CBZ with nitrendipine or omega-agatoxin-IVA produced further inhibition of 56 mmol/l K(+)-evoked 45Ca2+ influx and catecholamine secretion, compared to the effect of CBZ alone, whereas CBZ plus omega-conotoxin-GVIA did not produce any further inhibition. 5) CBZ (40 mumol/l) attenuated the production of cyclic GMP caused by muscarine. These results suggest that CBZ at therapeutic concentrations (16-48 mumol/l; 4-12 micrograms/ml) inhibits catecholamine secretion by interfering with nicotinic acetylcholine receptor-associated ion channels, voltage-dependent Na+ channels and N-type voltage-dependent Ca2+ channels, and may have an antimuscarinic effect in adrenal medullary cells.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8584045     DOI: 10.1007/bf00168560

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  28 in total

1.  Muscarinic receptor-mediated increase in cyclic GMP level in isolated bovine adrenal medullary cells.

Authors:  N Yanagihara; M Isosaki; T Ohuchi; M Oka
Journal:  FEBS Lett       Date:  1979-09-15       Impact factor: 4.124

2.  Three types of bovine chromaffin cell Ca2+ channels: facilitation increases the opening probability of a 27 pS channel.

Authors:  C R Artalejo; D J Mogul; R L Perlman; A P Fox
Journal:  J Physiol       Date:  1991-12       Impact factor: 5.182

3.  The action of volatile anaesthetics on stimulus-secretion coupling in bovine adrenal chromaffin cells.

Authors:  G Pocock; C D Richards
Journal:  Br J Pharmacol       Date:  1988-09       Impact factor: 8.739

4.  Different types of calcium channels mediate central synaptic transmission.

Authors:  T Takahashi; A Momiyama
Journal:  Nature       Date:  1993-11-11       Impact factor: 49.962

5.  Three types of Ca2+ channel trigger secretion with different efficacies in chromaffin cells.

Authors:  C R Artalejo; M E Adams; A P Fox
Journal:  Nature       Date:  1994-01-06       Impact factor: 49.962

6.  Anticonvulsant drugs alter plasma tryptophan concentrations in epileptic patients: implications for antiepileptic action and mental function.

Authors:  J A Pratt; P Jenner; A L Johnson; S D Shorvon; E H Reynolds
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-10       Impact factor: 10.154

7.  Separate binding and functional sites for omega-conotoxin and nitrendipine suggest two types of calcium channels in bovine chromaffin cells.

Authors:  J J Ballesta; M Palmero; M J Hidalgo; L M Gutierrez; J A Reig; S Viniegra; A G Garcia
Journal:  J Neurochem       Date:  1989-10       Impact factor: 5.372

8.  Lithium chloride stimulates catecholamine synthesis and secretion in cultured bovine adrenal medullary cells.

Authors:  T Terao; N Yanagihara; K Abe; F Izumi
Journal:  Biol Psychiatry       Date:  1992-05-15       Impact factor: 13.382

9.  The action of anticonvulsant drugs on the firing of locus coeruleus neurons: selective, activating effect of carbamazepine.

Authors:  H R Olpe; R S Jones
Journal:  Eur J Pharmacol       Date:  1983-07-15       Impact factor: 4.432

10.  Relationship between Ca2+ uptake and catecholamine secretion in primary dissociated cultures of adrenal medulla.

Authors:  R W Holz; R A Senter; R A Frye
Journal:  J Neurochem       Date:  1982-09       Impact factor: 5.372

View more
  9 in total

1.  Pharmacological discrimination between effects of carbamazepine on hippocampal basal, Ca(2+)- and K(+)-evoked serotonin release.

Authors:  Y Kawata; M Okada; T Murakami; A Kamata; G Zhu; S Kaneko
Journal:  Br J Pharmacol       Date:  2001-06       Impact factor: 8.739

Review 2.  Therapy in Sleep-Related Hypermotor Epilepsy (SHE).

Authors:  Gian Maria Asioli; Simone Rossi; Francesca Bisulli; Laura Licchetta; Paolo Tinuper; Federica Provini
Journal:  Curr Treat Options Neurol       Date:  2020-01-30       Impact factor: 3.598

3.  Mechanism of nicotine-evoked release of 3H-noradrenaline in human cerebral cortex slices.

Authors:  Ran-Sook Woo; Eun-Young Park; Min-Soo Shin; Min-Suk Jeong; Rong-Jie Zhao; Byuong-Soo Shin; Chul-Jin Kim; Jin-Woo Park; Kee-Won Kim
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

Review 4.  Mechanisms of action of carbamazepine and its derivatives, oxcarbazepine, BIA 2-093, and BIA 2-024.

Authors:  António F Ambrósio; Patrício Soares-Da-Silva; Caetana M Carvalho; Arsélio P Carvalho
Journal:  Neurochem Res       Date:  2002-02       Impact factor: 3.996

5.  Lamotrigine and carbamazepine affect differently the release of D-[3H]aspartate from mouse cerebral cortex slices: involvement of NO.

Authors:  I Afanas'ev; V Kudrin; K S Rayevsky; V Varga; P Saransaari; S S Oja
Journal:  Neurochem Res       Date:  1999-09       Impact factor: 3.996

6.  Determination of effects of antiepileptic drugs on SNAREs-mediated hippocampal monoamine release using in vivo microdialysis.

Authors:  T Murakami; M Okada; Y Kawata; G Zhu; A Kamata; S Kaneko
Journal:  Br J Pharmacol       Date:  2001-10       Impact factor: 8.739

7.  Assessment of the biomarkers of hepatotoxicity following carbamazepine, levetiracetam, and carbamazepine-levetiracetam adjunctive treatment in male Wistar rats.

Authors:  Opeyemi Samson Osuntokun; Ademola Adeniyi Babatunde; Gbola Olayiwola; Tope Gafar Atere; Olayemi Olutobi Oladokun; Kabiru Isola Adedokun
Journal:  Toxicol Rep       Date:  2021-03-10

8.  A novel missense creatine mutant of CaBP4, c.464G>A (p.G155D), associated with autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE), reduces the expression of CaBP4.

Authors:  Yuxiong Guo; Qinfei Miao; Yuxin Zhang; Chun Wang; Mingjuan Liang; Xueping Li; Weifeng Qiu; Gangan Shi; Qiongxiang Zhai; Zhihong Chen
Journal:  Transl Pediatr       Date:  2022-03

9.  Computer aided identification of sodium channel blockers in the clinical treatment of epilepsy using molecular docking tools.

Authors:  Uzma Shaheen; Jyothy Akka; Jitendra Singh Hinore; Amandeep Girdhar; Srinivas Bandaru; Tharaparambil Gangadharan Sumithnath; Anuraj Nayarisseri; Anjana Munshi
Journal:  Bioinformation       Date:  2015-03-31
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.